A Deadline is coming up on July 20, 2020 in the lawsuit for certain investors in CytomX Therapeutics, Inc. (NASDAQ:CTMX).
San Diego, CA -- (SBWIRE) -- 07/15/2020 -- The Shareholders Foundation announced that a deadline is coming up on July 20, 2020 in the lawsuit filed for certain investors of CytomX Therapeutics, Inc. (NASDAQ: CTMX).
Investors who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) have certain options and there are strict and short deadlines running. Deadline: July 20, 2020. NASDAQ: CTMX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff claims that between May 17, 2018, and May 13, 2020, the defendants failed to disclose to investors that CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program, that CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.